We are live on ! Find out more
MESO icon

Mesoblast

41 hedge funds and large institutions have $21.2M invested in Mesoblast in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more call options, than puts

Call options by funds: $4.6M | Put options by funds: $4.29M

0.33% less ownership

Funds ownership: 3.05% → 2.73% (-0.33%)

18% less funds holding

Funds holding: 50 → 41 (-9)

31% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 13

40% less capital inflows, than outflows

Capital inflows: $4.37M | Capital outflows: $7.29M

75% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 12

Holders
41
Holders Change
-9
Holders Change %
-18%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
9
Reduced
13
Closed
12
Calls
$4.6M
Puts
$4.29M
Net Calls
+$306K
Net Calls Change
+$2.66M

MESO Hedge Fund Activity: Q3 2021 in Review

41 of the 5,731 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q3 2021, worth a combined $21.2M — down 27% from $28.9M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of MESO and 3 opened new positions — a net loss of 9 holders — while 13 trimmed existing stakes and 9 added.

The largest buyer was M&G Investment Management, adding an estimated $3.66M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $2.42M sold.

  • 41 institutional investors held Mesoblast (MESO) as of Q3 2021, down from 50 in Q2 2021.
  • Funds reported $21.2M of Mesoblast stock for Q3 2021, down 27% quarter-over-quarter.
  • 3 funds opened new Mesoblast positions in Q3 2021 and 12 closed out, a net change of -9 holders.
  • The largest Mesoblast buyer in Q3 2021 was M&G Investment Management, an estimated $3.66M added.
  • The largest Mesoblast seller in Q3 2021 was Susquehanna International Group, an estimated $2.42M sold.

Based on aggregated 13F filings for Q3 2021.